Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998

Pediatric Blood and Cancer

Volumn 48, Issue 5, 2007, Pages 555-560

  Alston, R D ^a   Tatevossian, R G ^a,b   McNally, R J Q ^a   Kelsey, A ^b   Birch, J M ^a   Eden, T O B ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Incidence; Langerhans cell histiocytosis; Survival; Systems affected at diagnosis

Indexed keywords

ADOLESCENT; ARTICLE; CAUSE OF DEATH; DISEASE COURSE; FEMALE; FOLLOW UP; HISTIOCYTOSIS X; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RARE DISEASE; SCHOOL CHILD; SURVIVAL RATE; SYMPTOMATOLOGY; UNITED KINGDOM;

ADOLESCENT; AGE FACTORS; BONE AND BONES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ENGLAND; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; LIVER; MALE; SEASONS; SKIN; SURVIVAL RATE;

EID: 33947666223     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20884     Document Type: Article

References (21)

1. Laman JD, Leenen PJ, Annels NE, et al. Langerhans cell histiocytosis 'insight into DC biology'. Trends Immunol 2003; 24:190-196.
2. Carstensen H, Ornvold K. The epidemiology of Langerhans cell histiocytosis in children in Denmark, 1975-1989. Med Pediatr Oncol 1993;21:387-388.
3. Kaatsch P, Spix J. (2004) German childhood cancer registry-Annual report 2003 (1980-2002). Institute for Biostatistics, Epidemiology and Informatics (www.kinderkrebsregister.de) University of Mainz, 2003.
4. Muller J, Koos R, Garami M, et al. Experiences with Langerhans' cell histiocytosis in children in Hungary Magy Onkol 2004;48: 289-295.
5. McNally RJQ, Eden OB. An infectious aetiology for childhood acute leukaemia: A review of the evidence. Br J Haematol 2004; 127:243-263.
6. Glotzbecker MP, Carpentieri DF, Dormans JP. Langerhans cell histiocytosis: A primary viral infection of bone?: Human herpes virus 6 latent protein detected in lymphocytes from tissue of children. J Pediatr Orthop 2004;24:123-129.
7. Shimakage M, Sasagawa T, Kimura M, et al. Expression of Epstein-Barr virus in Langerhans' cell histiocytosis. Hum Pathol 2004;35:862-868.
8. Birch JM. Manchester children's tumour registry 1954-1970 and 1971-1983. In: Parkin DM, Stiller CA, Draper GJ, et al. editors. International incidence of childhood cancer. Lyon: IARC; 1988. pp 299-304.
9. Doll R, Cook P. Summarizing indices for comparison of cancer incidence data. Int J Cancer 1967;2:269-279.
10. McCullagh P, Nelder JP. Generalized linear models, 2nd edition London: Chapman and Hall; 1989.
11. Edwards JH. The recognition and estimation of cyclic trends. Ann Hum Genet 1961;25:83-86.
12. Cox DR. Regression models and life tables (with discussion). J R Stat Soc, Ser B 1972;34:187-220.
13. French Langerhans cell histiocytosis study group. A multicentre retrospective survey of Langerhans cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996;75: 17-24.
14. Minkov M, Frosch H, Steiner, et al. Langerhans cell histiocytosis in neonates. Pediatr Blood Cancer 2005;45:802-807.
15. Lavin PT, Osband ME. Evaluating the role of therapy in histiocytosis-X. Clinical studies, staging and scoring. Hematol Oncol Clin North Am 1987;1:35-47.
16. Raney RB, D'Angio. Langerhans cell histiocytosis (Histiocytosis X): Experience at the Children's Hospital of Philadelphia 1970-1984. Med Pediatr Oncol 1989;17:20-28.
17. Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 study group. Med Pediatr Oncol 1994;23:72-80.
18. Donadieu J, Piguet C, Bernard F, et al. A new Clinical score for disease activity in Langerhans cell histiocytosis. Pediatr Blood Cancer 2004;43:770-776.
19. Jubran RF, Marachelian A, Dorey F, et al. Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer 2005;45:37-42.
20. Braier J, Latella A, Balbancia B, et al. Outcome in children with pulmonary Langerhans cell histiocytosis. Pediatr Blood Cancer 2004;43:765-769.
21. Minkov M, Grois N, Heitger A, et al. DAL-HX Study Group Response to initial treatment of multisystem Langerhans cell histiocytosis: An important prognostic indicator. Med Pediatr Oncol 2002;39:581-585.